MedPath

Study of Visual-spatial Attention by Eye Tracking as a Function of Central or Peripheral Visual Impairment

Not Applicable
Terminated
Conditions
Central or Peripheral Visual Impairment
Interventions
Procedure: microperimetry
Procedure: visual acuity
Procedure: automated visual field
Procedure: eye movements recording
Registration Number
NCT03505398
Lead Sponsor
Nantes University Hospital
Brief Summary

The objective of this pilot work is to determine the role of central and peripheral visions in explicit attention processes (saccade planning) in the case of visual impairment.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Male or female ≥18 years;
  • Patient with a central visual deficit (central scotoma on the visual field: DMLA, cones dystrophy ...) or peripheral (annular scotoma: chronic glaucoma, retinitis pigmentosa ...) or without visual deficit (corrected visual acuity and visual field)
  • Patient agreeing to participate in the study and signing informed consent
  • Patient affiliated to social security
Read More
Exclusion Criteria
  • Pregnant woman
  • Patient with known epilepsy
  • Major under judicial safeguard, or deprived of liberty
  • Major under guardianship or curatorship or admitted to a health or social institution for purposes other than research.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controleye movements recording-
central vision disordermicroperimetry-
controlmicroperimetry-
central vision disordereye movements recording-
peripheral vision disordervisual acuity-
central vision disordervisual acuity-
central vision disorderautomated visual field-
peripheral vision disorderautomated visual field-
peripheral vision disordermicroperimetry-
peripheral vision disordereye movements recording-
controlvisual acuity-
controlautomated visual field-
Primary Outcome Measures
NameTimeMethod
Microperimetry recording (central versus peripheral)Day 0
recording of automated visual field (central versus peripheral)Day 0
Measurement of visual acuity (central versus peripheral)Day 0
recording of eye movements (central versus peripheral)Day 0
Secondary Outcome Measures
NameTimeMethod
recording of automated visual field (patient versus control)Day 0
Microperimetry recording (patient versus control)Day 0
recording of eye movements (patient versus control)Day 0
Measurement of visual acuity (patient versus control)Day 0

Trial Locations

Locations (1)

CHU de Nantes

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath